Skip To Main Content

Neurology

Sanofi Market Access logo. Science. Innovation. Value.

Neurology R&D

Using revolutionary technologies, Sanofi scientists are investigating targeted therapies for patients with neurological disorders

Our research investigates:

Illustration representing monoclonal antibodies.


Monoclonal antibodies

Illustration representing bispecific antibodies.


Bispecific antibodies

Icon representing small molecules.


Small molecules

Search for a specific clinical-stage project

FDA-approved products in neurology

Our current portfolio includes approved treatments for:

Icon representing multiple sclerosis.

Multiple sclerosis
 

Product information

Search for other FDA-approved products

Explore our other areas of focus

Illustration of human immune cells and antibodies to represent the therapeutic area of immunology and inflammation.

Immunology and inflammation

Learn more

Illustration of a tumor to represent the therapeutic area of oncology.

Oncology

Learn more

Illustration of a white blood cell, a red blood cell, and platelets to represent the therapeutic area of rare blood disorders.

Rare blood disorders

Learn more

Illustration of DNA strand to represent the therapeutic area of rare diseases.

Rare diseases

Learn more

Let’s connect

Schedule a meeting with a Sanofi Market Access team member to discuss how our therapies can bring value to your plan and members living with neurological disorders.

This site is intended for US payers only.
© 2024 Sanofi. All rights reserved.